Therapeutic effects of ranibizumab in patients with polypoidal choroidal vasculopathy

BACKGROUND: There is no consensus on the optimal initial treatment for polypoidal choroidal vasculopathy (PCV). Our study aimed to report the efficacy of repeated injections of intravitreal ranibizumab with or without photodynamic therapy for the treatment of PCV and to determine the possible factor...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Xiaoya, Yu, Xiaobing, Dai, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642544/
https://www.ncbi.nlm.nih.gov/pubmed/31324161
http://dx.doi.org/10.1186/s12886-019-1156-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642544/
https://www.ncbi.nlm.nih.gov/pubmed/31324161
http://dx.doi.org/10.1186/s12886-019-1156-4

Ejemplares similares